Neurosense Therapeutics Ltd
NRSN0.940USD
+0.070+8.03%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
23.12M시가총액
손실P/E TTM
자세한 내용은 Neurosense Therapeutics Ltd 회사
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Neurosense Therapeutics Ltd 정보
종목 코드 NRSN
회사 이름Neurosense Therapeutics Ltd
상장일Dec 09, 2021
CEOBen-Noon (Alon)
직원 수15
유형Ordinary Share
회계 연도 종료Dec 09
주소11 Hamenofim St.
도시HERZLIYA
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Israel
우편 번호4672562
전화97297996183
웹사이트https://www.neurosense-tx.com/
종목 코드 NRSN
상장일Dec 09, 2021
CEOBen-Noon (Alon)
Neurosense Therapeutics Ltd의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
3.18M
+93666.00%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
480.92K
+20916.00%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
189.62K
+66667.00%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
64.00K
--
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
24.00K
--
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Caren Deardorf
Ms. Caren Deardorf
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Revital Mandil-Levin, Ph.D.
Dr. Revital Mandil-Levin, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
3.18M
+93666.00%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
480.92K
+20916.00%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
189.62K
+66667.00%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
64.00K
--
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
24.00K
--
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Sat, Jan 31
마지막 업데이트: Sat, Jan 31
주주
주주 유형
주주
주주
비율
Ben-Noon (Alon)
10.69%
Rimon Gold Assets Ltd
7.76%
Eisenberg (Or)
1.62%
Tracik (Ferenc)
0.64%
Squarepoint Capital LLP
0.32%
기타
78.97%
주주
주주
비율
Ben-Noon (Alon)
10.69%
Rimon Gold Assets Ltd
7.76%
Eisenberg (Or)
1.62%
Tracik (Ferenc)
0.64%
Squarepoint Capital LLP
0.32%
기타
78.97%
주주 유형
주주
비율
Individual Investor
13.78%
Corporation
7.76%
Investment Advisor/Hedge Fund
0.37%
Investment Advisor
0.35%
Research Firm
0.15%
Hedge Fund
0.07%
Bank and Trust
0.05%
기타
77.47%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
30
293.14K
0.99%
-2.10M
2025Q3
29
437.13K
1.75%
-1.60M
2025Q2
37
7.64M
31.03%
+143.76K
2025Q1
39
7.45M
37.28%
+353.50K
2024Q4
38
7.90M
34.02%
+1.29M
2024Q3
32
5.18M
22.45%
-1.31M
2024Q2
35
6.62M
30.57%
+1.57M
2024Q1
38
5.18M
33.20%
-953.28K
2023Q4
38
5.12M
32.81%
-1.05M
2023Q3
33
5.76M
47.99%
-945.27K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Ben-Noon (Alon)
3.18M
10.69%
+93.67K
+3.04%
Apr 07, 2025
Rimon Gold Assets Ltd
2.30M
7.76%
+2.30M
--
Dec 02, 2024
Eisenberg (Or)
480.92K
1.62%
+20.92K
+4.55%
Apr 07, 2025
Tracik (Ferenc)
189.62K
0.64%
+66.67K
+54.22%
Apr 07, 2025
Squarepoint Capital LLP
95.38K
0.32%
+45.45K
+91.04%
Sep 30, 2025
Russek-Blum (Niva)
75.43K
0.25%
+10.00K
+15.28%
Apr 07, 2025
Leuchtenberger (Mark W)
64.00K
0.22%
--
--
Apr 07, 2025
Morgan Stanley & Co. LLC
41.40K
0.14%
-38.50K
-48.19%
Sep 30, 2025
Meitav Investment House Ltd
40.00K
0.13%
--
--
Sep 30, 2025
Binder (Hagit)
32.00K
0.11%
+10.00K
+45.45%
Apr 07, 2025
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
